Hertab 250MG Tablet (150’s) is a pharmaceutical product that contains Lapatinib as its active ingredient, with each tablet delivering a potent dose of 250 mg. This medication is primarily indicated for the treatment of certain types of breast cancer, particularly those that are HER2-positive, which means they overexpress the human epidermal growth factor receptor 2. Lapatinib works by inhibiting the activity of this receptor, thereby slowing down or stopping the growth of cancer cells. Hertab is often used in combination with other therapies, such as capecitabine, to enhance its effectiveness. The formulation is designed to provide a targeted approach to cancer treatment, making it a vital option for patients battling advanced or metastatic breast cancer. As a targeted therapy, Hertab aims to minimize damage to healthy cells while focusing on cancerous ones, which is a significant advantage over traditional chemotherapy.